Download PDF

Other users also viewed these articles

Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab Juan José Lerma Garrido; Antonio Gracia Pérez; Antonio Pérez Torres; Amalia Rueda Cid; Clara Molina Almela; María Dolores Pastor Cubillo; Cristina Campos Fernández; Isabel Balaguer Trull; Loreto Carmona; Javier Calvo Catalá;
Reumatol Clin. 2022;18:25-9
The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam Hai-Binh Bui; Hong-Thinh Lai; Thanh-Lam Nguyen; Thuy-Duong Vu; Nhat-Le Bui; Van-Hung Nguyen; Thi-To-Chau Tran; Thi-Phuong-Thuy Nguyen; Thi-Ngoc-Lan Nguyen; Jaffar A. Al-Tawfiq; Dinh-Toi Chu;
Reumatol Clin. 2024;20:128-35
Evaluation of serum IgG4 levels as a screening tool for IgG4-related disease: Data from a retrospective study Pablo Martínez Calabuig; Jorge Juan Fragío Gil; Roxana González Mazarío; Laura Salvador Maicas; Mireia Lucía Sanmartín Martínez; Antonio Sierra Rivera; Laura Abenza Barberá; María Cristina Sabater Abad; Francesc Puchades Gimeno; Inmaculada Castelló Miralles; Amalia Rueda Cid; Cristina Campos Fernández;
10.1016/j.reumae.2025.501852